Logo image of RBRK

RUBRIK INC-A (RBRK) Stock Fundamental Analysis

USA - NYSE:RBRK - US7811541090 - Common Stock

79.88 USD
+1.07 (+1.36%)
Last: 10/21/2025, 8:04:01 PM
79.8997 USD
+0.02 (+0.02%)
After Hours: 10/21/2025, 8:04:01 PM
Fundamental Rating

3

Taking everything into account, RBRK scores 3 out of 10 in our fundamental rating. RBRK was compared to 285 industry peers in the Software industry. RBRK may be in some trouble as it scores bad on both profitability and health. RBRK is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year RBRK has reported negative net income.
RBRK had a positive operating cash flow in the past year.
RBRK Yearly Net Income VS EBIT VS OCF VS FCFRBRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 -200M -400M -600M -800M -1B

1.2 Ratios

RBRK has a worse Return On Assets (-18.58%) than 70.53% of its industry peers.
Industry RankSector Rank
ROA -18.58%
ROE N/A
ROIC N/A
ROA(3y)-52.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RBRK Yearly ROA, ROE, ROICRBRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 100 -100 200

1.3 Margins

With a decent Gross Margin value of 77.96%, RBRK is doing good in the industry, outperforming 75.44% of the companies in the same industry.
In the last couple of years the Gross Margin of RBRK has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for RBRK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5YN/A
RBRK Yearly Profit, Operating, Gross MarginsRBRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50 -100

3

2. Health

2.1 Basic Checks

RBRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RBRK has been increased compared to 1 year ago.
RBRK has a better debt/assets ratio than last year.
RBRK Yearly Shares OutstandingRBRK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
RBRK Yearly Total Debt VS Total AssetsRBRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B

2.2 Solvency

RBRK has an Altman-Z score of 1.68. This is a bad value and indicates that RBRK is not financially healthy and even has some risk of bankruptcy.
RBRK has a Altman-Z score (1.68) which is comparable to the rest of the industry.
RBRK has a debt to FCF ratio of 6.21. This is a slightly negative value and a sign of low solvency as RBRK would need 6.21 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.21, RBRK is in line with its industry, outperforming 56.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.21
Altman-Z 1.68
ROIC/WACCN/A
WACC10.99%
RBRK Yearly LT Debt VS Equity VS FCFRBRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 200M -200M -400M -600M

2.3 Liquidity

RBRK has a Current Ratio of 1.82. This is a normal value and indicates that RBRK is financially healthy and should not expect problems in meeting its short term obligations.
RBRK has a Current ratio (1.82) which is comparable to the rest of the industry.
RBRK has a Quick Ratio of 1.81. This is a normal value and indicates that RBRK is financially healthy and should not expect problems in meeting its short term obligations.
RBRK has a Quick ratio (1.81) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.81
RBRK Yearly Current Assets VS Current LiabilitesRBRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.98% over the past year.
RBRK shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.72%.
Measured over the past years, RBRK shows a very strong growth in Revenue. The Revenue has been growing by 20.54% on average per year.
EPS 1Y (TTM)61.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.5%
Revenue 1Y (TTM)47.72%
Revenue growth 3Y20.54%
Revenue growth 5YN/A
Sales Q2Q%51.19%

3.2 Future

The Earnings Per Share is expected to grow by 30.80% on average over the next years. This is a very strong growth
RBRK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.39% yearly.
EPS Next Y78.93%
EPS Next 2Y39.65%
EPS Next 3Y30.8%
EPS Next 5YN/A
Revenue Next Year43.16%
Revenue Next 2Y34.05%
Revenue Next 3Y30.39%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RBRK Yearly Revenue VS EstimatesRBRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
RBRK Yearly EPS VS EstimatesRBRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.5 -0.5 -1 -1.5 -2

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RBRK. In the last year negative earnings were reported.
Also next year RBRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBRK Price Earnings VS Forward Price EarningsRBRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

RBRK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 86.83
EV/EBITDA N/A
RBRK Per share dataRBRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as RBRK's earnings are expected to grow with 30.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.65%
EPS Next 3Y30.8%

0

5. Dividend

5.1 Amount

RBRK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RUBRIK INC-A

NYSE:RBRK (10/21/2025, 8:04:01 PM)

After market: 79.8997 +0.02 (+0.02%)

79.88

+1.07 (+1.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-09 2025-09-09/amc
Earnings (Next)12-05 2025-12-05
Inst Owners70.48%
Inst Owner Change0.49%
Ins Owners2.5%
Ins Owner Change23.56%
Market Cap15.77B
Analysts82.96
Price Target117 (46.47%)
Short Float %7.85%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)72.6%
Min EPS beat(2)53.87%
Max EPS beat(2)91.34%
EPS beat(4)4
Avg EPS beat(4)62.03%
Min EPS beat(4)48.45%
Max EPS beat(4)91.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.25%
Min Revenue beat(2)4.87%
Max Revenue beat(2)7.64%
Revenue beat(4)4
Avg Revenue beat(4)6.88%
Min Revenue beat(4)4.87%
Max Revenue beat(4)8.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.09%
EPS NQ rev (1m)3.17%
EPS NQ rev (3m)36.09%
EPS NY rev (1m)50.19%
EPS NY rev (3m)50.19%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)5.81%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)4.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.57
P/FCF 86.83
P/OCF 74.73
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.57
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.92
FCFY1.15%
OCF(TTM)1.07
OCFY1.34%
SpS5.48
BVpS-2.86
TBVpS-3.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.58%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.96%
FCFM 16.78%
ROA(3y)-52.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5YN/A
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.21
Debt/EBITDA N/A
Cap/Depr 94.25%
Cap/Sales 2.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.81
Altman-Z 1.68
F-Score5
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)109.27%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.5%
EPS Next Y78.93%
EPS Next 2Y39.65%
EPS Next 3Y30.8%
EPS Next 5YN/A
Revenue 1Y (TTM)47.72%
Revenue growth 3Y20.54%
Revenue growth 5YN/A
Sales Q2Q%51.19%
Revenue Next Year43.16%
Revenue Next 2Y34.05%
Revenue Next 3Y30.39%
Revenue Next 5YN/A
EBIT growth 1Y58.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year68.98%
EBIT Next 3Y36.5%
EBIT Next 5YN/A
FCF growth 1Y188.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1167.46%
OCF growth 3YN/A
OCF growth 5YN/A